Taurine in women with a history of gestational diabetes

Diabetes Research and Clinical Practice

Volumn 76, Issue 2, 2007, Pages 187-192

  Seghieri, Giuseppe ^a   Tesi, Federica ^a   Bianchi, Loria ^a   Loizzo, Alberto ^b   Saccomanni, Giuseppe ^c   Ghirlanda, Giovanni ^d   Anichini, Roberto ^a   Franconi, Flavia ^e  

^a Spedali Riuniti ^*  (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

Gestational diabetes; Insulin secretion; Plasma taurine; Post pregnancy follow up

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; TAURINE;

ADULT; AMINO ACID BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPOTHESIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; REGRESSION ANALYSIS; TAURINE;

EID: 33947262025     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.08.008     Document Type: Article

References (40)

1. Catalano P.M., Tyzbir E.D., Roman N.M., Amini S.B., and Sims E.A.H. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am. J. Obstet. Gynecol. 165 (1991) 1667-1672
2. Moses G.R. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabet. Care 19 (1996) 1348-1350
3. Peters R.K., Kjos S.L., Xiang A., and Buchanan T.A. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347 (1996) 227-230
4. Catalano P.M., Tyzbir E.D., Wolfe R.R., Calles J., Roman N.M., Amini S.B., et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am. J. Physiol. 264 (1993) E60-E67
5. Catalano P.M., Huston L., Amini S.B., and Kalhan S.C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am. J. Obstet. Gynecol. 180 (1999) 903-916
6. Ryan E.A., Imes S., Liu D., McManus R., Finegood D.T., Polonsky K.S., et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44 (1995) 506-512
7. Kautzky-Willer, Prager R., Waldhausl W., Pacini G., Thomaseth K., Wagner O.F., et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabet. Care 20 (1997) 1717-1723
8. Osei K., Gaillard T.R., and Schuster D.P. History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes. Diabet. Care 21 (1998) 1250-1257
9. Homko C., Sivan E., Chen X., Reece E.A., and Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 86 (2001) 568-573
10. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes. Diabet. Care 25 (2002) 1862-1868
11. Kautzky-Willer, Pacini G., Tura A., Bieglmayer C., Schneider B., Ludvik B., et al. Increased plasma leptin in gestational diabetes. Diabetologia 44 (2001) 164-172
12. Winkler G., Cseh K., Baranyi E., Melczer Z., Speer G., Hajos P., et al. Tumor necrosis factor system and insulin resistance in gestational diabetes. Diabet. Res. Clin. Pract. 56 (2002) 93-99
13. Retnakaran R., Hanley A.J., Raif N., Connelly P.W., Sermer M., and Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J. Clin. Endocrinol. Metab. 88 (2003) 3507-3512
14. Retnakaran R., Hanley A.J., Raif N., Hirning C.R., Connelly P.W., Sermer M., et al. Adiponectin and beta cell dysfunction in gestational diabetes patho-physiological implications. Diabetologia 48 (2005) 993-1001
15. Williams M.A., Qiu C., Muy-Rivera M., Vadachkoria S., Song T., and Luthy D.A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 2306-2311
16. Hansen S.H. The role of taurine in diabetes mellitus and development of diabetic complications. Diabet. Metab. Res. Rev. 17 (2001) 330-346
17. Franconi F., Di Leo M.A.S., Bennardini F., and Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus?. Neurochem. Res. 29 (2004) 143-150
18. Franconi F., Loizzo A., Ghirlanda G., and Seghieri G. Taurine supplementation in diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care 9 (2006) 32-36
19. Aerts L., and Van Assche F.A. Taurine and taurine-deficiency in the perinatal period. J. Perinatal. Med. 30 (2002) 281-286
20. Dahri S., Snoeck A., Reusens-Billen B., Remacle C., and Hoet J.J. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40 Suppl. 2 (1991) 115-120
21. Cherif H., Reusens B., Ahn M.T., Hoet J.J., and Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J. Endocrinol. 159 (1998) 341-348
22. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 61 (1995) 1115-1119
23. De Luca G., Calpona P.R., Caponetti A., Romano G., Di Benedetto A., Cucinotta D., et al. Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetes mellitus. Metabolism 50 (2001) 60-64
24. Wijekoon E.P., Skinner C., Brosnan M.E., and Brosnan J.T. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can. J. Physiol. Pharmacol. 82 (2004) 506-514
25. 1H NMR and HPLC-MS-based metabonomic study of urine from obese [fa/fa] Zucker and normal Wistar-derived rats. J. Pharmaceut. Biomed. Anal. 3 (2005) 465-471
26. Weijers R.N., Bekedam D.J., and Smulders Y.M. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabet. Care 25 (2002) 72-77
27. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabet. Care 22 (1999) 462-1470
28. Kirwan J.P., Huston-Presley H., Kalhan S.C., and Catalano P.M. Clinically useful estimates of insulin sensitivity during pregnancy. Diabet. Care 24 (2001) 1602-1607
29. Carpenter M.W., and Coustan D.R. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144 (1982) 768-773
30. Andereson M.E.J., Lean G., Vespasiani M., and Bruni V. Development of a barcode system for nutrient analysis in the UK. AS Diabetologia 35 Suppl. 1 (1992) A165
31. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., et al. Taurine levels in plasma and platelets in insulin-dependent and non-insulin dependent diabetes mellitus: correlation with platelet aggregation. In: Huxtable R., and Michalk D.V. (Eds). Taurine in Health and Disease (1994), Plenum Press, New York, NY 419-424
32. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72 (1992) 101-163
33. Stipanuk M.H. Role of liver in the regulation of body cysteine and taurine levels: a brief review. Neurochem. Res. 29 (2004) 105-110
34. Schuller-Levis G., and Park E. Taurine: new applications for an old amino acid. FEMS Microbiol. Lett. 226 (2003) 195-202
35. Cetin, Nobile de Santis M.S., Taricco E., Radaelli T., Teng C., Ronzoni S., et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am. J. Obstet. Gynecol. 192 (2005) 610-617
36. + channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes. Biochem. Pharmacol. 68 (2004) 901-910
37. Han J., Bae J.H., Kim S.Y., Lee H.Y., Jang B.C., Lee I.K., et al. Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E1008-E1018
38. Arany E., Strutt B., Romanus P., Remacle C., Reusens B., and Hill D.J. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice. Diabetologia 47 (2004) 1831-1837
39. Chang K.J., and Kwon W. Immunohistochemical localization of insulin in pancreatic beta-cells of taurine-supplemented or taurine-depleted diabetic rats. Adv. Exp. Med. Biol. 483 (2000) 579-587
40. Brons C., Spohr C., Storgaard H., Dyerberg J., and Vaag A. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur. J. Clin. Nutr. 58 (2004) 1239-1247